ADMA Biologics, Inc.

NasdaqGM:ADMA

Sector

🏥 Health Care

Industries

🧬 Biotechnology

💊 Pharmaceuticals

Location

United States

Market Cap

USD 4.00 B

Share Price

USD 16.76

Avg Daily Volume

3,063,714

Change (1 day)

2.32%

Change (1 year)

1.88%

Change (YTD)

-2.27%

ADMA Biologics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 32.73%

ADMA Biologics, Inc. EBIT Margin is 32.73% for the Trailing 12 Months (TTM) ending June 30, 2025, a 83.24% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

ADMA Biologics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was 17.86%, a -324.49% change year over year.
ADMA Biologics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -7.96%, a -85.04% change year over year.
ADMA Biologics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -53.20%, a -49.29% change year over year.
ADMA Biologics, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -104.91%, a -22.25% change year over year.